Objectives
To establish the point prevalence of pathological laughing and crying (PLC) in multiple sclerosis (MS). To define associated neurological, emotional, and cognitive correlates of PLC.
Design
A consecutive sample of 152 patients with clinically or laboratory definite MS were screened for PLC, defined as sudden, involuntary displays of laughing or crying or both, without associated subjective feelings of depression or euphoria. Thereafter, a case-control design was followed with patients with PLC matched to patients with MS without PLC on age, gender, physical disability (Expanded Disability Status Scale), duration of MS, and premorbid IQ.
Setting
An MS outpatient clinic, the population representative of a large urban catchment area.
Patients
Fifteen of 152 patients had PLC, 11 of whom (mean [SD] age, 43.7 [8.3] years, 7 women) agreed to further testing. Thirteen patients with MS without PLC acted as controls.
Main Outcome Measures
Neurological examination, Pathological Laughter and Crying Scale, Hospital Anxiety and Depression Scale, 28-item General Health Questionnaire, and the Wechsler Adult Intelligence Scale-Revised.
Results
The point prevalence of PLC in MS was 10%. Patients had a mean Expanded Disability Status Scale score of 6.5, had had MS for a mean (SD) of 10 (5.8) years, and had entered a chronic-progressive phase of their illness. Pathological laughing and crying was not associated with disease exacerbations. Compared with controls, patients were not more depressed or anxious, but had a greater decline in IQ.
Conclusions
Pathological laughing and crying as distinct from emotional lability affects 1 in 10 patients with MS. It occurs in severely physically disabled patients, generally with long-standing disease. The presence of cognitive deficits relative to controls implies more extensive brain involvement.
Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.
Haussleiter et al.
Therapeutic Advances in Neurological Disorders 2009;2:13-29.
ABSTRACT
Pathological Laughter in a Patient With Multiple Sclerosis
Hoegerl and Zboray
J Am Osteopath Assoc 2008;108:409-411.
ABSTRACT
| FULL TEXT
Predictors of well-being among significant others of persons with multiple sclerosis
Sherman et al.
Mult Scler 2007;13:238-249.
ABSTRACT
Abnormal pontine activation in pathological laughing as shown by functional magnetic resonance imaging.
Kosaka et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:1376-1380.
ABSTRACT
| FULL TEXT
Pathologic laughing and intractable hiccups can occur early in multiple sclerosis.
de Seze et al.
Neurology 2006;67:1684-1686.
ABSTRACT
| FULL TEXT
The neuropsychiatry of multiple sclerosis
Jefferies
Adv. Psychiatr. Treat. 2006;12:214-220.
ABSTRACT
| FULL TEXT
A prospective study of predictors of poststroke depression
Carota et al.
Neurology 2005;64:428-433.
ABSTRACT
| FULL TEXT
Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients
Smith et al.
Mult Scler 2004;10:679-685.
ABSTRACT
Neural correlates of laughter and humour
Wild et al.
Brain 2003;126:2121-2138.
ABSTRACT
| FULL TEXT
Symptomatic therapy for underrecognized manifestations of multiple sclerosis
Krupp and Rizvi
Neurology 2002;58:S32-39.
ABSTRACT
| FULL TEXT
Pathological laughter and crying: A link to the cerebellum
Parvizi et al.
Brain 2001;124:1708-1719.
ABSTRACT
| FULL TEXT
